Featured Research

from universities, journals, and other organizations

Immune System And Intestinal Bacteria: The Key To Balanced Cohabitation

Date:
November 18, 2008
Source:
CNRS
Summary:
Researchers have just discovered a key mechanism that maintains the essential balance between bacteria living in our intestine and the immune system controlling them. Their research, published in the journal Nature, paves the way for new forms of treatment for infectious diseases of the intestine, such as dysentery, or chronic inflammatory diseases, such as Crohn's disease.

Researchers from the Institut Pasteur, CNRS and Inserm have just discovered a key mechanism that maintains the essential balance between bacteria living in our intestine and the immune system controlling them.

Their research, published in the journal Nature, paves the way for new forms of treatment for infectious diseases of the intestine, such as dysentery, or chronic inflammatory diseases, such as Crohn's disease.

There are billions of bacteria in our intestine. These bacteria are not harmful, but help with digestion and also play a protective role by forming a barrier around the intestine, thus preserving it from attacks by pathogenic organisms. But, when their development ceases to be regulated, they can proliferate and become pathogenic themselves. The balance between these bacteria, known as commensals, and the immune system controlling them, is therefore essential. Changes in this balance can cause severe intestinal diseases, such as Crohn's disease, or other chronic inflammatory conditions with serious sequelae.

In an article published in Nature, Gerard Eberl and his Lymphoid Tissue Development Group at the Institut Pasteur (CNRS, URA1961) give a step-by-step description of a mechanism that maintains this subtle balance between intestinal commensal flora and the immune system. In particular, the researchers demonstrate how certain bacteria trigger an immune response leading to the formation of new lymphoid tissues responsible for modulating their development.

The scientists first show that an essential component of the bacterial wall, recognized by a protein in the epithelial cells of the intestine, triggers the first step of an immune chain reaction. This reaction leads to the formation of lymphoid tissues which, in turn, secrete immunoglobulins. It is these small molecules that control the bacterial flora on the surface of the intestine.

Above all, in cooperation with Ivo Gomperts Boneca and his Biology and Genetics of the Bacterial Cell Wall Group (Institut Pasteur/AVENIR Inserm Team), Gιrard Eberl's team demonstrate that, once isolated, the bacterial cell wall component can alone induce this regulation mechanism. Thus, thanks to this molecule, researchers hope to contribute to the development of new forms of treatment against inflammatory diseases of the intestine and intestinal infections.


Story Source:

The above story is based on materials provided by CNRS. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bouskra et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature, Nov 5, 2008; DOI: 10.1038/nature07450

Cite This Page:

CNRS. "Immune System And Intestinal Bacteria: The Key To Balanced Cohabitation." ScienceDaily. ScienceDaily, 18 November 2008. <www.sciencedaily.com/releases/2008/11/081114185942.htm>.
CNRS. (2008, November 18). Immune System And Intestinal Bacteria: The Key To Balanced Cohabitation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/11/081114185942.htm
CNRS. "Immune System And Intestinal Bacteria: The Key To Balanced Cohabitation." ScienceDaily. www.sciencedaily.com/releases/2008/11/081114185942.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins